India Glycols Limited has informed the Exchange regarding 'Notice of Meeting of the Unsecured Creditors of India Glycols Limited convened by the Hon'ble National Company Law Tribunal, Allahabad Bench, Prayagraj'.
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 2.2 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
India Glycols Limited has issued the notice for a meeting of its unsecured creditors, ordered by the NCLT Allahabad Bench on 15th January 2026 and 16th February 2026, to vote on a Scheme of Arrangement. Under the scheme, the company's Spirits & Biofuel undertaking will be demerged into IGL Spirits Limited, and its Biopharma undertaking into Ennature Bio Pharma Limited, while the listed parent retains its bio-based specialties and performance chemicals business. The unsecured creditors' meeting is scheduled for 24th March 2026 at 2:00 PM via video conferencing, with remote e-voting open from 20th to 23rd March 2026. The total unsecured creditor amount stood at approximately ₹1,12,010.63 lakh as on 15th November 2025. The resulting companies are proposed to be listed on BSE and NSE upon scheme approval, and the move aims to unlock value by giving each business independent focus and investor appeal.
If approved, shareholders of India Glycols will receive equity shares in the two resulting listed entities (Ennature Bio Pharma and IGL Spirits), in addition to their existing holding in the demerged company. This restructuring is aimed at sharper business focus and potential value unlocking, but the share entitlement ratio and fairness opinion are key items shareholders should review before the equity shareholders' meeting.